Analysis of the chronic wound microbiota of 2,963 patients by 16S rDNA pyrosequencing

Wound Repair and Regeneration

Volumn 24, Issue 1, 2016, Pages 163-174

  Wolcott, Randall D ^a   Hanson, John D ^b   Rees, Eric J ^b   Koenig, Lawrence D ^b   Phillips, Caleb D ^b   Wolcott, Richard A ^b,c   Cox, Stephen B ^b   White, Jennifer S ^c  

^a Southwest Regional Wound Care Center Lubbock   (United States)

^b Research and Testing Laboratory   (United States)

^c Pathogenius Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA 16S; RNA 16S;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANAEROCOCCUS VAGINALIS; ARTICLE; BACTEROIDES FRAGILIS; BIOFILM; CHRONIC WOUND; CORYNEBACTERIUM JEIKEIUM; CORYNEBACTERIUM STRIATUM; CORYNEBACTERIUM TUBERCULOSTEARICUM; DECUBITUS; DELFTIA ACIDOVORANS; DEMOGRAPHY; DIABETIC FOOT; DNA SEQUENCE; ENTEROBACTER HORMAECHEI; ENTEROCOCCUS FAECALIS; FEMALE; FINEGOLDIA MAGNA; FLAVOBACTERIUM SUCCINICANS; FUSOBACTERIUM NUCLEATUM; HUMAN; LEG ULCER; MAJOR CLINICAL STUDY; MALE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MICROFLORA; MIDDLE AGED; NONHUMAN; PREVOTELLA BIVIA; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; PYROSEQUENCING; RALSTONIA PICKETTII; RETROSPECTIVE STUDY; SERRATIA NEMATODIPHILA; SPECIES COMPOSITION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS LUGDUNENSIS; STAPHYLOCOCCUS PETTENKOFERI; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SALIVARIUS; SURGICAL WOUND; CHRONIC DISEASE; CORYNEBACTERIUM; CORYNEBACTERIUM INFECTIONS; GENETICS; INJURY; ISOLATION AND PURIFICATION; MICROBIOLOGY; PSEUDOMONAS; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; UNITED STATES; VARICOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; CORYNEBACTERIUM; CORYNEBACTERIUM INFECTIONS; DIABETIC FOOT; FEMALE; HUMANS; MALE; MICROBIOTA; MIDDLE AGED; PRESSURE ULCER; PSEUDOMONAS; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; RNA, RIBOSOMAL, 16S; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; SURGICAL WOUND; UNITED STATES; VARICOSE ULCER; WOUNDS AND INJURIES;

EID: 84949895696     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12370     Document Type: Article

References (62)

1. Tuttle MS., Association between microbial bioburden and healing outcomes in venous leg ulcers: a review of the evidence. Adv Wound Care 2015; 4: 1-11.
2. O'Meara S, Al-Kurdi D, Ologun Y, Ovington LG, Martyn-St James M, Richardson R., Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev 2014; 1: CD003557.
3. Abbas M, Uckay I, Lipsky BA., In diabetic foot infections antibiotics are to treat infection, not to heal wounds. Expert Opin Pharmacother 2015; 16: 1-12.
4. Howell-Jones RS, Price PE, Howard AJ, Thomas DW., Antibiotic prescribing for chronic skin wounds in primary care. Wound Repair Regen 2006; 14: 387-93.
5. Lipsky BA, Armstrong DG, Citron DM, Tice AD, Morgenstern DE, Abramson MA., Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet 2005; 366: 1695-703.
6. Dowd SE, Sun Y, Secor PR, Rhoads DD, Wolcott BM, James GA, et al., Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 2008; 8: 43.
7. Hoiby N, Bjarnsholt T, Moser C, Bassi GL, Coenye T, Donelli G, et al., ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. Clin Microbiol Infect 2015; 21: S1-25.
8. Kim M, Ashida H, Ogawa M, Yoshikawa Y, Mimuro H, Sasakawa C., Bacterial interactions with the host epithelium. Cell Host Microbe 2010; 8: 20-35.
9. Costerton JW, Stewart PS, Greenberg EP., Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318-22.
10. Stoodley P, Sauer K, Davies DG, Costerton JW., Biofilms as complex differentiated communities. Annu Rev Microbiol 2002; 56: 187-209.
11. Stewart PS, Costerton JW., Antibiotic resistance of bacteria in biofilms. Lancet 2001; 358: 135-8.
12. Lam JS, MacDonald LA, Lam MY, Duchesne LG, Southam GG., Production and characterization of monoclonal antibodies against serotype strains of Pseudomonas aeruginosa. Infect Immun 1987; 55: 1051-7.
13. Leid JG, Willson CJ, Shirtliff ME, Hassett DJ, Parsek MR, Jeffers AK., The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J Immunol 2005; 175: 7512-8.
14. Torres VJ, Stauff DL, Pishchany G, Bezbradica JS, Gordy LE, Iturregui J, et al., A Staphylococcus aureus regulatory system that responds to host heme and modulates virulence. Cell Host Microbe 2007; 1: 109-19.
15. Baruch M, Belotserkovsky I, Hertzog BB, Ravins M, Dov E, McIver KS, et al., An extracellular bacterial pathogen modulates host metabolism to regulate its own sensing and proliferation. Cell 2014; 156: 97-108.
16. Wolcott RD, Rhoads DD, Dowd SE., Biofilms and chronic wound inflammation. J Wound Care 2008; 17: 333-41.
17. Tam VC, Serruto D, Dziejman M, Brieher W, Mekalanos JJ., A type III secretion system in Vibrio cholerae translocates a formin/spire hybrid-like actin nucleator to promote intestinal colonization. Cell Host Microbe 2007; 1: 95-107.
18. Veiga E, Guttman JA, Bonazzi M, Boucrot E, Toledo-Arana A, Lin AE, et al., Invasive and adherent bacterial pathogens co-Opt host clathrin for infection. Cell Host Microbe 2007; 2: 340-51.
19. Preston GM., Metropolitan microbes: type III secretion in multihost symbionts. Cell Host Microbe 2007; 2: 291-4.
20. Mills E, Baruch K, Charpentier X, Kobi S, Rosenshine I., Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli. Cell Host Microbe 2008; 3: 104-13.
21. Mimuro H, Suzuki T, Nagai S, Rieder G, Suzuki M, Nagai T, et al., Helicobacter pylori dampens gut epithelial self-renewal by inhibiting apoptosis, a bacterial strategy to enhance colonization of the stomach. Cell Host Microbe 2007; 2: 250-63.
22. Rohde JR, Breitkreutz A, Chenal A, Sansonetti PJ, Parsot C., Type III secretion effectors of the IpaH family are E3 ubiquitin ligases. Cell Host Microbe 2007; 1: 77-83.
23. Madsen JS, Burmolle M, Hansen LH, Sorensen SJ., The interconnection between biofilm formation and horizontal gene transfer. FEMS Immunol Med Microbiol 2012; 65: 183-95.
24. Elias S, Banin E., Multi-species biofilms: living with friendly neighbors. FEMS Microbiol Rev 2012; 36: 990-1004.
25. Carlsson J., Bacterial metabolism in dental biofilms. Adv Dent Res 1997; 11: 75-80.
26. Weimer KE, Juneau RA, Murrah KA, Pang B, Armbruster CE, Richardson SH, et al., Divergent mechanisms for passive pneumococcal resistance to beta-lactam antibiotics in the presence of Haemophilus influenzae. J Infect Dis 2011; 203: 549-55.
27. Tuttle MS, Mostow E, Mukherjee P, Hu FZ, Melton-Kreft R, Ehrlich GD, et al., Characterization of bacterial communities in venous insufficiency wounds by use of conventional culture and molecular diagnostic methods. J Clin Microbiol 2011; 49: 3812-9.
28. Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, Eskan MA, et al., Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 2011; 10: 497-506.
29. Hendricks KJ, Burd TA, Anglen JO, Simpson AW, Christensen GD, Gainor BJ., Synergy between Staphylococcus aureus and Pseudomonas aeruginosa in a rat model of complex orthopaedic wounds. J Bone Joint Surg Am 2001; 83: 855-61.
30. Mikamo H, Kawazoe K, Izumi K, Watanabe K, Ueno K, Tamaya T., Studies on the pathogenicity of anaerobes, especially Prevotella bivia, in a rat pyometra model. Infect Dis Obstet Gynecol 1998; 6: 61-5.
31. Hoffman LR, Deziel E, D'Argenio DA, Lepine F, Emerson J, McNamara S, et al., Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 2006; 103: 19890-5.
32. Fux CA, Costerton JW, Stewart PS, Stoodley P., Survival strategies of infectious biofilms. Trends Microbiol 2005; 13: 34-40.
33. Rhoads DD, Cox SB, Rees EJ, Sun Y, Wolcott RD., Clinical identification of bacteria in human chronic wound infections: culturing vs. 16S ribosomal DNA sequencing. BMC Infect Dis 2012; 12: 321.
34. Rhoads DD, Wolcott RD, Sun Y, Dowd SE., Comparison of culture and molecular identification of bacteria in chronic wounds. Int J Mol Sci 2012; 13: 2535-50.
35. Human Microbiome Project C. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207-14.
36. Bailey MT, Walton JC, Dowd SE, Weil ZM, Nelson RJ., Photoperiod modulates gut bacteria composition in male Siberian hamsters (Phodopus sungorus). Brain Behav Immun 2010; 24: 577-84.
37. Wolcott RD, Gontcharova V, Sun Y, Dowd SE., Evaluation of the bacterial diversity among and within individual venous leg ulcers using bacterial tag-encoded FLX and titanium amplicon pyrosequencing and metagenomic approaches. BMC Microbiol 2009; 9: 226.
38. Huse SM, Huber JA, Morrison HG, Sogin ML, Welch DM., Accuracy and quality of massively parallel DNA pyrosequencing. Genome Biol 2007; 8: R143.
39. Quince C, Lanzen A, Davenport RJ, Turnbaugh PJ., Removing noise from pyrosequenced amplicons. BMC Bioinformatics 2011; 12: 38.
40. Edgar RC., Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010; 26: 2460-1.
41. Edgar RC., UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods 2013; 10: 996-8.
42. Edgar RC., MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 2004; 32: 1792-7.
43. Edgar RC., MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics 2004; 5: 113.
44. Price MN, Dehal PS, Arkin AP., FastTree 2-approximately maximum-likelihood trees for large alignments. PLoS One 2010; 5: e9490.
45. Price MN, Dehal PS, Arkin AP., FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol 2009; 26: 1641-50.
46. Clarke KR, Somerfield PJ, Chapman MG., On resemblance measures for ecological studies, including taxonomic dissimilarities and a zero-adjusted Bray-Curtis coefficient for denuded assemblages. J Exp Mar Bio Ecol 2006; 330: 55-80.
47. Hochberg Y, Benjamini Y., More powerful procedures for multiple significance testing. Stat Med 1990; 9: 811-8.
48. Gardner SE, Hillis SL, Heilmann K, Segre JA, Grice EA., The neuropathic diabetic foot ulcer microbiome is associated with clinical factors. Diabetes 2013; 62: 923-30.
49. Dowd SE, Wolcott RD, Sun Y, McKeehan T, Smith E, Rhoads D., Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS One 2008; 3: e3326.
50. Citron DM, Goldstein EJ, Merriam CV, Lipsky BA, Abramson MA., Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol 2007; 45: 2819-28.
51. Lipsky BA., Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection? Clin Microbiol Infect 2007; 13: 351-3.
52. Dowd SE, Sun Y, Secor PR, Rhoads DD, Wolcott BM, James GA, Wolcott RD., (2008). Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol, 8, 43.
53. Bowler PG, Davies BJ., The microbiology of infected and noninfected leg ulcers. Int J Dermatol 1999; 38: 573-8.
54. Gallo RL., S. epidermidis influence on host immunity: more than skin deep. Cell Host Microbe 2015; 17: 143-4.
55. Scharschmidt TC, Fischbach MA., What lives on our skin: ecology, genomics and therapeutic opportunities of the skin microbiome. Drug Discov Today Dis Mech 2013; 10: pii: e83-e89.
56. Naik S, Bouladoux N, Linehan JL, Han SJ, Harrison OJ, Wilhelm C, et al., Commensal-dendritic-cell interaction specifies a unique protective skin immune signature. Nature 2015; 520: 104-8.
57. Agarwal A, Singh KP, Jain A., Medical significance and management of staphylococcal biofilm. FEMS Immun Med Microbiol 2010; 58: 147-60.
58. Wolcott RD, Cox SB, Dowd SE., Healing and healing rates of chronic wounds in the age of molecular pathogen diagnostics. J Wound Care 2010; 19: 272-8, 280-1.
59. Hammer ND, Reniere ML, Cassat JE, Zhang Y, Hirsch AO, Indriati Hood M, et al., Two heme-dependent terminal oxidases power Staphylococcus aureus organ-specific colonization of the vertebrate host. MBio 2013; 4: pii: e00241-13.
60. Asai K, Yamada K, Yagi T, Baba H, Kawamura I, Ohta M., Effect of incubation atmosphere on the production and composition of staphylococcal biofilms. J Infect Chemother 2015; 21: 55-61.
61. Chmiel JF, Aksamit TR, Chotirmall SH, Dasenbrook EC, Elborn JS, LiPuma JJ, et al., Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi. Ann Am Thorac Soc 2014; 11: 1298-306.
62. Stephens P, Wall IB, Wilson MJ, Hill KE, Davies CE, Hill CM, et al., Anaerobic cocci populating the deep tissues of chronic wounds impair cellular wound healing responses in vitro. Br J Dermatol 2003; 148: 456-66.